Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
23.34
+0.28 (1.21%)
At close: Sep 22, 2026, 4:00 PM EDT
23.36
+0.02 (0.09%)
After-hours: Sep 22, 2026, 4:54 PM EDT
Odyssey Therapeutics Employees
Odyssey Therapeutics had 100 employees as of June 30, 2026.
Employees
100
Change
n/a
Growth
n/a
Revenue / Employee
$990
Profits / Employee
-$1,600,270
Market Cap
1.12B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 100 | - | - |
| Mar 31, 2026 | 100 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 704 |
| MannKind | 592 |
| Replimune Group | 465 |
| Maze Therapeutics | 141 |
| Apnimed | 81 |
| Vor Biopharma | 76 |
| Alto Neuroscience | 68 |
| Seaport Therapeutics | 58 |
ODTX News
- 6 days ago - Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum - GlobeNewsWire
- 8 days ago - Odyssey Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 13 days ago - H.C. Wainwright has increased confidence in Odyssey after Beeline data - TheFly
- 26 days ago - Odyssey Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 27 days ago - Odyssey Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Evotec enters R&D collaboration with Odyssey Therapeutics - TheFly
- 6 weeks ago - Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases - PRNewsWire
- 7 weeks ago - Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire